With March in the rear view window, the Investing News Network (INN) presents a closer look at the biggest stories for the marijuana investing market last month.

Two critical cannabis markets — the US and Canada — held the attention of investors. As Florida lifted a ban on smokable products, companies were able to start selling the popular products, boosting predictions for the performance of this state.

In Canada, as Ontario prepared for the opening of its retail market, further deals were signed between publicly traded marijuana companies and some of the 25 lottery winners looking to open shops.

Cannabis accessory developer and retail operator High Tide (CSE:HITI,OTC Pink:HTDEF) signed its third store agreement in Ontario, securing a spot in Toronto.

“As the realities of a compressed schedule and complex project became clear, the third winner realized that they would benefit from our help,” Raj Grover, president and CEO of High Tide, said in a release.

Canopy Growth (NYSE:CGC,TSX:WEED) secured a second branding deal for a store in Ontario, this time by lending the Tokyo Smoke brand to a location near the popular Yonge-Dundas Square in Toronto.

The Tokyo Smoke shop completed its public notice period on Tuesday (April 2). Bruce Linton, co-CEO of Canopy, previously told INN he hopes the brands attract consumers; for Canopy, the focus is on keeping cannabis supply up for the province.

Meanwhile, Canadian producer HEXO (NYSEAMERICAN:HEXO,TSX:HEXO) announced a plan to purchase Newstrike Brands (TSXV:HIP,OTC Pink:NWKRF) in a deal worth C$275.9 million.

As a result of the acquisition, HEXO will become more established with retailer Inner Spirit Holdings (CSE:ISH) due to Newstrike’s partnership with Inner Spirit. The stores from the public retailer, dubbed Spiritleaf, carry a special hub dedicated to the Up Cannabis brand from Newstrike. The stores include images from Canadian rock band The Tragically Hip, which has invested in Newstrike.

“We welcome and look forward to working with the HEXO team and building on the foundation that has been put in place,” Darren Bondar, president and CEO of Inner Spirit, told INN in an email statement.

Florida boosts performance of MSOs

The cannabis market in Florida was in the spotlight as smokable products were finally allowed to be sold in the state. The sunshine state was also in focus thanks to developments from some multi-state operators (MSOs) active in the market.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Trulieve Cannabis (CSE:TRUL,OTC Pink:TCNNF) took advantage of the lift on smokable items to inform shareholders that these products will be available in its stores.

“Offering these whole flower products to our patients in their purest, most effective form is something we — and patients — have been looking forward to since we opened the doors of the state’s first dispensary,” Kim Rivers, CEO of Trulieve, said in a press release.

During a fiscal Q4 2018 results conference call, Joseph Lusardi, CEO of Curaleaf (CSE:CURA,OTCQX:CURLF), said he is expecting the market to double thanks to this policy change. He indicated that the company also expects to see some form of policy around edibles sometime this year.

Also last month, fellow MSO Cresco Labs (CSE:CL,OTCQX:CRLBF) confirmed the purchase of a stake in the promising Florida market. The company will pay US$120 million for local company VidaCann, which will grant it seven active dispensaries with more on the way.

Watch the video above for more on what happened during the month of March.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Inner Spirit Holdings and High Tide are clients of the Investing News Network. This article is not paid-for content.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.


US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less
  • Q3 Systemwide Pro Forma Revenue increased 18% quarter-over-quarter to $22.3 million , 170% year-over-year – Company became cash flow positive from operations in August
  • Company sale leaseback transaction with Innovative Industrial Properties scheduled to close within two weeks. As a result of close, together with proceeds from the recently closed bought deal financing, the Company will have $16 million of cash and $43 million in long-term debt
  • Company is in the process of acquiring acreage to construct up to 210,000 square feet of flowering canopy and supporting manufacturing facility in Cook County, Illinois to exponentially increase capacity in state
  • Initial guidance for 2021 with Systemwide Pro Forma Revenue of $170 -180 million and Adjusted EBITDA of $40 -50 million
  • The Company’s existing projects at maturity represent a long-term revenue and EBITDA opportunity upwards of $650 million and $250 million

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) today announced its financial results for the third quarter of 2020. All financial information is presented in U.S. dollars unless otherwise indicated.

Third Quarter 2020 Financial Results Highlights

Keep reading... Show less

Shareholders with losses exceeding $50,000 are encouraged to contact the firm

The Law Offices of Frank R. Cruz reminds investors of the upcoming December 1, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB ) securities between February 13, 2020 and September 4, 2020 , inclusive (the “Class Period”).

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less